发明名称 |
HETEROCYCLIC COMPOUND AND USE THEREFOR |
摘要 |
The present invention provides a compound having cholinergic muscarinic M1 receptor positive allosteric modulator activity, that is useful as a drug for preventing or treating Alzheimer's disease, schizophrenia, pain, sleep disorders, and the like. The present invention pertains to a compound expressed by formula (I) or a salt thereof. (In the formula, R1 represents an optionally substituted amino group, or an optionally substituted cyclic amino group; R2 and R3 each independently represent a hydrogen atom or a substitution group; X represents -CH= or -N=; and ring A represents an optionally substituted 5 through 10 membered ring.) |
申请公布号 |
WO2013129622(A1) |
申请公布日期 |
2013.09.06 |
申请号 |
WO2013JP55566 |
申请日期 |
2013.02.28 |
申请人 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED |
发明人 |
SAKAMOTO, HIROKI;SUGIMOTO, TAKAHIRO |
分类号 |
C07D215/56;A61K31/47;A61K31/4709;A61K31/502;A61K31/5377;A61P25/04;A61P25/18;A61P25/20;A61P25/28;A61P43/00;C07D237/28;C07D401/10;C07D401/12;C07D405/12 |
主分类号 |
C07D215/56 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|